KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, will be presenting at the 2nd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference on October 6, 2011 at 3:45 p.m. at the New York Academy of Medicine in New York City.
